On November 10 and November 28, 2016, the fifth and sixth of 10 participants completed their 12-month follow-up interviews in ourIsraeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Moshe Kotler, M.D., this Phase 2 study has treated 10 subjects with chronic, treatment-resistant PTSD from any cause. Learn more…